From 0d1dd69a06708c933c86844fa9b49ca79cabddcc Mon Sep 17 00:00:00 2001 From: Don Armstrong Date: Sun, 16 Feb 2014 14:59:33 -0800 Subject: [PATCH] tweak multimarkdown citations slightly --- resume/research_statement.mdwn | 20 ++++++++++---------- 1 file changed, 10 insertions(+), 10 deletions(-) diff --git a/resume/research_statement.mdwn b/resume/research_statement.mdwn index 92026d2..70283a3 100644 --- a/resume/research_statement.mdwn +++ b/resume/research_statement.mdwn @@ -51,18 +51,18 @@ I developed novel bioinformatic methods which increase likelihood of identifying reproducible genetic associations using prior knowledge from publicly available databases and expert -information [#Armstrong2008:function2gene]. Using these methods, I -was able to identify genes previously unassociated with SLE in a +information [#Armstrong2008:function2gene]. Using these methods, I was +able to identify genes previously unassociated with SLE in a trio-based study [#Jacob2007:ar_lupus]. These genes were then replicated in a larger case-control study which was funded by the NIH -on the basis of the original findings -[#Jacob2009:sle_irak1],[#Armstrong2009:sle_gi]. Among other findings, -this larger study identified a missense allele in NCF2 (H389Q, -rs17849502) which was associated with SLE. Collaborative work -indicated that H389Q altered the binding energy of NCF2 with VAV1 -using docking simulations, and in vitro experiments confirmed that -H389Q altered NADPH oxidase function [#Jacob2012:sle_ncf2], thus -identifying it as a causative SLE mutation. +on the basis of the original findings [#Jacob2009:sle_irak1] , +[#Armstrong2009:sle_gi]. Among other findings, this larger study +identified a missense allele in NCF2 (H389Q, rs17849502) which was +associated with SLE. Collaborative work indicated that H389Q altered +the binding energy of NCF2 with VAV1 using docking simulations, and in +vitro experiments confirmed that H389Q altered NADPH oxidase function +[#Jacob2012:sle_ncf2], thus identifying it as a causative SLE +mutation. ## Cancer Stem Cells in Glioblastoma -- 2.39.2